ClinicalTrials.Veeva

Menu

Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and Survival (MLSP)

I

Institut Paoli-Calmettes

Status

Unknown

Conditions

Acute Myeloid Leukemia

Treatments

Behavioral: Conventional
Behavioral: WITH Comprehensive Geriatric assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT01188330
MLSP/IPC 2009-003

Details and patient eligibility

About

Acute myeloid leukaemia (AML) is a disease of the elderly, with a median age at diagnosis of 65. A poor outcome in this population has been well established, with very short overall survival (OS) and disease free survival (DFS).There are numerous bad prognostic factors related to the disease itself or to the patient's medical condition.

This study will evaluate the impact of a Comprehensive Geriatric assessment (CGA) performed at diagnosis with planned interventions according to disabilities and monthly follow-up by a nurse practitioner during 6 months on functional status of older cancer patients treated for Acute myeloid leukaemia. Functional status will be assessed with the Lawson Instrumental Activities of Daily Living (IADL) scale at diagnosis and 6 months after randomisation.

Enrollment

100 estimated patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged 70 years and older
  • Referred for treatment following a diagnosis of acute myeloid leukaemia.
  • signed informed consent

Exclusion criteria

  • Terminal patients, with a life expectancy estimated to be less than 3 months, will be excluded from the study, due to ethical issues and the fact that they are unlikely to benefit from this evaluation.
  • Patients unable to give informed consent.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

WITH Comprehensive Geriatric assessment
Experimental group
Description:
Conventional haematological management of patients and Comprehensive Geriatric assessment (CGA) at diagnosis followed by interventions according to disabilities detected and planned monthly follow up by a nurse practitioner during 6 months.
Treatment:
Behavioral: WITH Comprehensive Geriatric assessment
Conventional
Active Comparator group
Description:
Conventional haematological management of patients
Treatment:
Behavioral: Conventional

Trial contacts and locations

2

Loading...

Central trial contact

Dominique GENRE, MD; Agnès BOYER CHAMMARD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems